Neurocrine (NASDAQ: NBIX) CRO sells 2,261 shares after option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NEUROCRINE BIOSCIENCES INC Chief Regulatory Officer Ingrid Delaet reported an option exercise combined with a routine share sale. On May 29, 2026, she exercised non-qualified stock options for 2,261 shares of common stock at an exercise price of $79.02 per share and sold 2,261 shares in an open-market transaction at $156.71 per share. After these transactions, she directly held 16,225 shares of common stock. The sale was executed by a broker under a pre-arranged Rule 10b5-1 trading plan adopted on February 27, 2026, which company policy does not allow her to amend or modify after adoption.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 2,261 shares ($354,321)
Net Sell
3 txns
Insider
Delaet Ingrid
Role
Chief Regulatory Officer
Sold
2,261 shs ($354K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option | 2,261 | $0.00 | -- |
| Exercise | Common Stock | 2,261 | $79.02 | $179K |
| Sale | Common Stock | 2,261 | $156.71 | $354K |
Holdings After Transaction:
Non-Qualified Stock Option — 0 shares (Direct, null);
Common Stock — 18,486 shares (Direct, null)
Footnotes (1)
- The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. The option was granted January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022.
Key Figures
Shares sold: 2,261 shares
Sale price: $156.71 per share
Option exercise price: $79.02 per share
+5 more
8 metrics
Shares sold
2,261 shares
Open-market sale of common stock on May 29, 2026
Sale price
$156.71 per share
Average price for 2,261 NBIX shares sold May 29, 2026
Option exercise price
$79.02 per share
Exercise price for 2,261 non-qualified stock option shares
Shares held after
16,225 shares
Direct NBIX common stock holdings after transactions
Option grant date
January 31, 2022
Grant date of the non-qualified stock option exercised
Option expiration
January 31, 2032
Expiration date of the exercised non-qualified stock option
10b5-1 plan adoption
February 27, 2026
Adoption date of the Rule 10b5-1 trading plan
Options exercised
2,261 options
Non-qualified stock options converted into common shares
Key Terms
Rule 10b5-1 trading plan, Non-Qualified Stock Option, open-market sale, Exercise or conversion of derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option financial
"security_title: "Non-Qualified Stock Option" with 2,261 underlying common shares..."
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
open-market sale financial
"transaction_action: "open-market sale" for 2,261 shares of common stock..."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security" for the option exercise..."
vesting in 48 equal monthly installments financial
"The option was granted January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022..."
FAQ
What insider transactions did NBIX Chief Regulatory Officer Ingrid Delaet report?
Ingrid Delaet reported exercising options for 2,261 NBIX shares at $79.02 and selling 2,261 shares at $156.71. These same-day transactions reflect an exercise-and-sell pattern, converting an option position into cash while maintaining a remaining direct shareholding.
What NBIX stock options did Ingrid Delaet exercise according to this Form 4?
She exercised a non-qualified stock option for 2,261 underlying NBIX shares with a $79.02 exercise price. The option was granted on January 31, 2022 and vested in 48 equal monthly installments beginning February 28, 2022, with expiration on January 31, 2032.